Blood Transfusion Diagnostics Market Research Report - Forecast to 2023

Blood Transfusion Diagnostics Market Research Report - Forecast to 2023

ID: MRFR/HC/0620-HCRR | July, 2018 | Region: Global | 200 pages | Half-Cooked Research Reports

Global Blood Transfusion Diagnostics Information, by product (Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations, others) by Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test, others) by end user (Hospitals, Clinics, Blood banks, Laboratories) - Forecast till 2023


Study objectives:


Main objective of this research is to provide information about Blood Transfusion Diagnostics market, product, technology and end users.



  • To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the Blood Transfusion Diagnostics market.

  • To provide insights about factors affecting the market growth.

  • To analyze the Blood Transfusion Diagnostics market based on various factors- Price Analysis, Supply Chain Analysis, Porters’ Five Force Analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies - Americas, Europe, Asia Pacific and Middle East & Africa and their countries.

  • To provide country level analysis of the market with respect to the current market size and future prospective.

  • To provide country level analysis of the market for segments by product, by technology, by end and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Blood Transfusion Diagnostics market.


Intended Audience



  • Medical device manufactures

  • Medical devices suppliers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Academic Medical Institutes and Universities


Figure 1: Global Blood Transfusion Diagnostics market, by technology, 2016:


 Blood Transfusion Diagnostics market


Source: Press Release, Company presentation, annual reports


Figure 2: Market Synopsis

Blood Transfusion Diagnostics Synopsis


 Sources: Press Release, presentation, company website, annual reports, government records, journals expert interview.


Market Scenario:


Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood components are of great importance to laboratories and hospitals during an emergency or a critical case of large volume of blood loss. RBC transfusion is done when hemoglobin levels fall below 100g/L. Blood collected from the donor has to be screened for a number of infectious disease before transfusion. Thus, blood transfusion diagnostics play an important role in blood transfusion in order to avoid infection to both the receiver and healthcare staff. Rising prevalence of infectious diseases, increasing in number of blood transfusion procedures, demand for screened blood products and increasing campaigning or awareness programs drive the growth of this market. Demand of blood and blood products exceeds over their supply thus contributing to the growth of this market. Global market of Blood Transfusion Diagnostics is expected to reach USD 2.45 billion in 2023 from USD 1.50 billion in 2016 with a CAGR of approximately 8.2% during the forecast period 2017-2023.


Segmentation:


Global Blood Transfusion Diagnostics market has been segmented on the basis of blood product including Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations and other products. On the basis of technology, the market is segmented into Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test and other technologies. ELISA is further segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassays (FIA), and colorimetric immunoassay (CI). Nucleic Acid Amplification is segmented into Thermomechanical analysis (TMA) and real-time PCR. End users are hospitals, clinics, blood banks, laboratories.


Regional Analysis:


Globally, Blood Transfusion Diagnostics market consists of four regions Americas, Europe, Asia Pacific and Middle East and Africa. America is the largest market whose growth is attributed to an increase in the use of nucleic acid amplification test and large number of awareness programs conducted by the government bodies and non-government organizations. Europe is the second largest market. Asia Pacific is showing positive growth this market. The market shows steady growth in Middle East & Africa.


Key Players


Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), Roche Diagnostics (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Immucor (U.S),  Siemens Healthineers (Germany), Ortho Clinical Diagnostics, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Ortho Clinical Diagnostics (U.S), Beckman Coulter (U.S), Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany),  DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain).


The report for Blood Transfusion Diagnostics market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Table of Contents



1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Threats

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & supply: gap analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Up-Coming trends in Blood Transfusion Diagnostics market

5.7.1 Market trends

5.7.2 Technological trends

6. Global Blood Transfusion Diagnostics market by product

6.1 Red Blood Cells

6.2 Platelets

6.3 Plasma

6.4 Albumin

6.5 Immunoglobulin Preparations

7. Global Blood Transfusion Diagnostics market by technology

7.1 Western Blot

7.2 ELISA

7.2.1 Chemiluminescence immunoassay

7.2.2 Fluorescence immunoassays

7.3.3 Colorimetric immunoassay

7.3 Nucleic Acid Amplification

7.3.1 Thermomechanical analysis (TMA)

7.3.2 Real-time PCR

7.4 Fluorescence assay

7.5 Rapid Test

8. Global Blood Transfusion Diagnostics market by end user

8.1 Hospitals

8.2 Clinics

8.3 Blood banks

8.4 Laboratories

9. Global Blood Transfusion Diagnostics market by region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 UK

9.3.1.3 France

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Republic of Korea

9.4.5 Australia

9.4.6 Rest of Asia-Pacific

9.5 Middle East and Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Qatar

9.5.5 Kuwait

9.5.6 Rest of Middle East and Africa

10 Competitive Landscape

11 Company Profile

11.1 Grifols

11.1.1 Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financial Updates

11.1.4 Key Developments

11.2 Thermo Fisher Scientific, Inc.

11.2.1 Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financial Updates

11.2.4 Key Developments

11.3 Roche Diagnostics

11.3.1 Overview

11.3.2 Product/Business Segment Overview

11.3.3 Financial Updates

11.3.4 Key Developments

11.4 Biomérieux

11.4.1 Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Updates

11.4.4 Key Development

11.5 Bio-Rad Laboratories, Inc.

11.5.1 Overview

11.5.2 Product/Business Segment Overview

11.5.3 Financial Updates

11.5.4 Key Developments

11.6 Immucor

11.6.1 Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Updates

11.6.4 Key Developments

11.7 Siemens Healthineers

11.7.1 Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financial Updates

11.7.4 Key Developments

11.8 Becton, Dickinson and Company

11.8.1 Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financial Updates

11.8.4 Key Developments

11.9 Others

12 Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Blood Transfusion Diagnostics Industry

13 Appendix





LIST OF TABLES



Table 1 Blood Transfusion Diagnostics Industry Synopsis, 2017–2023

Table 2 Global Blood Transfusion Diagnostics Market Estimates & Forecast, 2017–2023, (USD Million)

Table 3 Global Blood Transfusion Diagnostics Market, by Region, 2017–2023, (USD Million)

Table 4 Global Blood Transfusion Diagnostics Market, by Product, 2017–2023, (USD Million)

Table 5 Global Blood Transfusion Diagnostics Market, by Technology, 2017–2023, (USD Million)

Table 6 Global Blood Transfusion Diagnostics Market, by End-User, 2017–2023, (USD Million)

Table 7 Americas Blood Transfusion Diagnostics Market, by Product, 2017–2023, (USD Million)

Table 8 Americas Blood Transfusion Diagnostics Market, by Technology, 2017–2023, (USD Million)

Table 9 Americas Blood Transfusion Diagnostics Market, by End-User, 2017–2023, (USD Million)

Table 10 North America Blood Transfusion Diagnostics Market, by Product, 2017–2023, (USD Million)

Table 11 North America Blood Transfusion Diagnostics Market, by Technology, 2017–2023, (USD Million)

Table 12 North America Blood Transfusion Diagnostics Market, by End-User, 2017–2023, (USD Million)

Table 13 South America Blood Transfusion Diagnostics Market, by Product, 2017–2023, (USD Million)

Table 14 South America Blood Transfusion Diagnostics Market, by Technology, 2017–2023, (USD Million)

Table 15 South America Blood Transfusion Diagnostics Market, by End-User, 2017–2023, (USD Million)

Table 16 Europe Blood Transfusion Diagnostics Market, by Product, 2017–2023, (USD Million)

Table 17 Europe Blood Transfusion Diagnostics Market, by Technology, 2017–2023, (USD Million)

Table 18 Europe Blood Transfusion Diagnostics Market, by End-User, 2017–2023, (USD Million)

Table 19 Western Europe Blood Transfusion Diagnostics Market by Product, 2017–2023, (USD Million)

Table 20 Western Europe Blood Transfusion Diagnostics Market, by Technology, 2017–2023, (USD Million)

Table 21 Western Europe Blood Transfusion Diagnostics Market, by End-User, 2017–2023, (USD Million)

Table 22 Eastern Europe Blood Transfusion Diagnostics Market, by Product, 2017–2023, (USD Million)

Table 23 Eastern Europe Blood Transfusion Diagnostics Market, by Technology, 2017–2023, (USD Million)

Table 24 Eastern Europe Blood Transfusion Diagnostics Market, by End-User, 2017–2023, (USD Million)

Table 25 Asia Pacific Blood Transfusion Diagnostics Market, by Product, 2017–2023, (USD Million)

Table 26 Asia Pacific Blood Transfusion Diagnostics Market, by Technology, 2017–2023, (USD Million)

Table 27 Asia Pacific Blood Transfusion Diagnostics Market, by End-User, 2017–2023, (USD Million)

Table 28 Middle East & Africa Blood Transfusion Diagnostics Market, by Product, 2017–2023, (USD Million)

Table 29 Middle East & Africa Blood Transfusion Diagnostics Market, by Technology, 2017–2023, (USD Million)

Table 30 Middle East & Africa Blood Transfusion Diagnostics Market, by End-User, 2017–2023, (USD Million) 



LIST OF FIGURES



Figure 1 Research Process

Figure 2 Segmentation for Global Blood Transfusion Diagnostics Market

Figure 3 Segmentation Market Dynamics for Blood Transfusion Diagnostics Market

Figure 4 Global Blood Transfusion Diagnostics Market Share, by Product 2016

Figure 5 Global Blood Transfusion Diagnostics Market Share, by Technology 2016

Figure 6 Global Blood Transfusion Diagnostics Market Share, by End Users, 2016

Figure 7 Global Blood Transfusion Diagnostics Market Share, by Region, 2016

Figure 8 Americas Blood Transfusion Diagnostics Market Share, by Country, 2016

Figure 9 Europe Blood Transfusion Diagnostics Market Share, by Country, 2016

Figure 10 Asia Pacific Blood Transfusion Diagnostics Market Share, by Country, 2016

Figure 11 Middle East & Africa Blood Transfusion Diagnostics Market Share, by Country, 2016

Figure 12 Global Blood Transfusion Diagnostics Market: Company Share Analysis, 2016 (%)